Ethics and Issues: How to be a leader in practice changeAdvice for ‘regular pharmacists’ who want to be leaders in practice change. Every day should be a vitamin D dayThere have probably been more reports on vitamin D this year than on any other health issue. Here’s why Letter: Questioning the role of DPP-4 inhibitors A reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. Drug News: Finacea, FluMist, Intanza Finacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. Celiac disease: the stealthy robber of health There are many myths and misconceptions surrounding celiac disease. Dealing with grievances under new regulations With regulation, expected to come soon, techs will be held to the same standards pharmacists are accustomed to and will be accountable to the Ontario College of Pharmacists (OCP). Divulge personal health to colleges only: CMPA CIHR panel nixes study of controversial MS treatment Advisory group doesn’t rule out future trial, when there’s adequate evidence Ontario MDs cycle with Lance Armstrong Reinventing depression instruments in clinical practice Primary-care physicians and nurse practitioners adapt rating scales for the real world First Previous 2109 2110 2111 2112 2113 Next Last
